At this time, posts about Yeongjin Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have tentatively sold a net 179,000 shares of Yeongjin Pharmaceutical, while institutions have bought a net 7,000 shares. Yeongjin Pharmaceutical is known as a specialty pharmaceutical company under the KT&G group.

As of 12:30 PM on the 5th, Yeongjin Pharmaceutical's stock price is 6,760 KRW, up 3.21% from the previous day, with a trading volume of 6,481,997 shares, which is about 90.77% of the average trading volume on the 5th. On July 27, Yeongjin Pharmaceutical became an issue in the market with the headline "Sharp Drop... Review of Dexacotisil Reproduction."

In addition to Yeongjin Pharmaceutical, posts from investors are also rapidly increasing regarding Shinil Pharmaceutical (012790), Hanmi Pharmaceutical (128940), and Hanmi Global (053690).

※Source: AI Investment Assistant AI Lassi-ro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing